A case report on the long-term survival of a patient with HER2-positive metastatic gastric adenocarcinoma and a short review of the current literature

被引：1
|
作者：
Puhr, Hannah Christina [1 ,2 ]
Ilhan-Mutlu, Ayseguel [1 ,2 ]
机构：
[1] Med Univ Vienna, Div Oncol, Dept Med 1, Vienna, Austria
[2] Med Univ Vienna, Upper Gastrointestinal Tumors Unit, Comprehens Canc Ctr Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2020年 / 13卷 / 04期
关键词：
Gastric cancer; Upper GI cancer; HER2; Trastuzumab; Ramucirumab; GASTROESOPHAGEAL JUNCTION CANCER; HER2; STATUS; OPEN-LABEL; TRASTUZUMAB; CHEMOTHERAPY; ESOPHAGEAL; PROGNOSIS;
D O I：
10.1007/s12254-020-00649-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The prognosis of patients with metastatic gastroesophageal cancer remains poor despite numerous promising clinical trials, and the clinical benefit of systemic therapies is under critical review. This case report of a patient with human epidermal growth factor receptor 2 (HER2)-positive metastatic gastric adenocarcinoma is an impulse for the importance of individual decision making and molecular guided treatment options.
引用
收藏
页码：453 / 458
页数：6
相关论文
共 50 条
  • [11] Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma
    Curea, Fabiana G.
    Hebbar, Mohamed
    Ilie, Silvia M.
    Bacinschi, Xenia E.
    Trifanescu, Oana G.
    Botnariuc, Inga
    Anghel, Rodica M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 32 (10) : 351 - 363
  • [12] LapatinibDevelopment of resistance to metastatic HER2-positive gastric cancer: case report
    Reactions Weekly, 2018, 1697 (1) : 221 - 221
  • [13] Long-Term Survival with Metastatic Carcinoid Tumors: A Case Report and Review of the Literature
    Zacharias, David G.
    Jensen, Mark H.
    Farley, David R.
    JOURNAL OF SURGICAL EDUCATION, 2010, 67 (02) : 99 - 102
  • [14] Long-term survival in HER2-positive metastatic breast cancer: The first blow is half the battle
    Steenbruggen, T. G.
    van Ramshorst, M. S.
    Stouthard, J. M. L.
    Rodenhuis, S.
    Linn, S. C.
    Sonke, G. S.
    Smorenburg, C. H.
    CANCER RESEARCH, 2017, 77
  • [15] Trastuzumab in HER2-Positive Metastatic Gastric CancerProfile Report
    Jamie D. Croxtall
    Kate McKeage
    BioDrugs, 2011, 25 : 257 - 259
  • [16] Long-Term Survival in Metastatic Pancreatic Cancer. A Case Report and Review of the Literature
    Spinelli, Gian Paolo
    Zullo, Angelo
    Romiti, Adriana
    Di Seri, Marisa
    Tomao, Federica
    Miele, Evelina
    Spalletta, Bruno
    Eramo, Annarita
    Hassan, Cesare
    Tomao, Silverio
    JOURNAL OF THE PANCREAS, 2006, 7 (05): : 486 - 491
  • [17] Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer
    Harano, K.
    Lei, X.
    Gonzalez-Angulo, A. M.
    Murthy, R. K.
    Valero, V.
    Mittendorf, E. A.
    Ueno, N. T.
    Hortobagyi, G. N.
    Chavez-MacGregor, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (02) : 367 - 374
  • [18] Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer
    K. Harano
    X. Lei
    A. M. Gonzalez-Angulo
    R. K. Murthy
    V. Valero
    E. A. Mittendorf
    N. T. Ueno
    G. N. Hortobagyi
    M. Chavez-MacGregor
    Breast Cancer Research and Treatment, 2016, 159 : 367 - 374
  • [19] Predictors of long-term survival in a large cohort of patients with HER2-positive (HER2+) metastatic breast cancer (MBC)
    Gregor, M. A. C.
    Chavez, M.
    Lei, X.
    Giordano, S. H.
    Valero, V.
    Esteva, F.
    Mittendorf, E. A.
    Gonzalez-Angulo, A. M.
    Hortobagyi, G. N.
    CANCER RESEARCH, 2012, 72
  • [20] HER2-Positive Neuroendocrine Breast Cancer: Case Report and Review of Literature
    Gevorgyan, Arpine
    Bregni, Giacomo
    Galli, Giulia
    Zanardi, Elisa
    de Braud, Filippo
    Di Cosimo, Serena
    BREAST CARE, 2016, 11 (06) : 424 - 426
12345